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Week 2:
CON 68.7 ± 3.2 133 ± 14 646 ± 99 58.4 ± 1.3 291 ± 13
DCM 40.9 ± 4.1' 184 ± 16' 519 ± 40 60.7 ± 1.9 316 ± 9
OCM/AT-Block 44.1 ± 3.7* 138 ± 10+ 540 ± 56 632 ± 1.2' 325 ± 9
Week4:
CON 73.1 ± 2.4 127 ± 10 629 ± 45 57.6 ± 14 314 ± 9
DCM 35.2 ± 3.5' 223 ± 16' 505±41' 62.0 ± 1.9 313 ± 9
DCM/AT-Block 35.2 ± 2.7' 160± 13'+ 578 ± 48 65.7 ± 1.5' 296 ± 6
C
P
FU
EF: ejection fraction, LMM: muscle mass index (g/m2 ). EOV: end-diastolic volume index
(ml!m2I. EDP: end-diastolic pressure (mmHg). 'p < 0.05 vs. P t P < 0.05 vs. C
Thus: Myocardial inflammation in patients with dilated cardiomyopathy
causes a pronounced increase of diastolic myocardial stiffness. Sponta-
neous resolvement of inflammatory signs is parallaled by improvement of
LV diastOlic, but not systolic function.
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Left Ventricular (LV) and Myocyte Electrophysiology
with the Development of Dilated Cardiomyopathy
(DCM); Effects of Angiotensin II Receptor (ATl AT-II)
Blockade
William S. McMahon, Rupak Mukherjee, Henry H. Holzgrefe, David S. Buckles,
Paul C. Gillette, James R. Powell, William H. Koster, Francis G. Spinale Med Univ of
South Carolina, Chas, SC; Bristol Myers Squibb Research Institute, Princeton, NJ
Ventricular arrhythmias are asignificant cause of morbidity and mortality with
DCM, and ATl AT-II receptor activation has been implicated to playa role in
arrhythmogenesis. However, the effects of AT1, AT-II receptor activation on
changes in LV function and myocyte electrophysiology during the progres-
sion of DCM remain unexplored. Accordingly, this study measured weekly
changes in LV function (ejection fraction, LVEF; peak systolic wall stress,
LVWS) and surface electrocardiography (R-R interval, ORS duration, OTc in-
terval), and myocyte action potentials (resting membrane, RM; upstroke ve-
locity, Vmax; duration at 90% repolarization, APD90) at terminal study in 3
groups of dogs (n = 6/group): DCM, chronic pace (216 bpm, 4 weeks);
DCM/AT-BLOCK, chronic pace and treatment with a specific non-peptide AT1
AT-II antagonist (SR 47436 (BMS 186295); 30 mg/kg BID); and control (CON)
All measurements were made with the pacemaker deactivated.
With DCM, RM (-71 ± l' vs -78 ± 1 mV) and APD90 (257 ± 9' vs 226
± 7 ms) increased, and Vmax decreased (121 ± 5' vs 158 ± 9V/s) com-
pared to CON. In contrast, with AT-BLOCK, RM became more negative (-76
± 1+ mV), APDgO was reduced (183 ± 14'+) and Vmax increased (165 ±
13+). Summary: AT1 AT-II receptor blockade during the progression of DCM
caused significant changes in LV myocardial conduction and myocyte action
potentials. These results suggest that AT1 AT-II receptor activation plays a
contributory role toward the changes in LV electrophysiology with DCM.
'p < 0.05 vs CON, +p < 0.05 vs OCM
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1799-31 Left Ventricular Function and Immunohistological
Findings in Patients with Dilated Cardiomyopathy: A
Follow-up Study
Igor Janda, Mira C. Schannwell, Otto N. Krogmann, Uwe Kuhl, Heinz
P Schultheiss 1, Bodo E. Strauer. 1Dept of Cardiology, Benjamin Franklin, Berlin;
University of Dusseldorf. Germany
Right ventricular endomyocardial biopsies and biplane left ventricular (LV) an-
giocardiography with high fidelity pressure measurements were performed
in 32 patients (pts) with dilated cardiomyopathy. LV systolic function was
assessed by the ejection fraction (ef; %). Parameters of LV diastolic func-
tion were: time constant of relaxation (T; ms). constant of myocardial stiff-
ness (stress-strain relationship, b) and the relation of early to late peak filling
rate (epfr/lpfr). Immunohistological evaluation revealed lymphocytic infiltra-
tion and increased expression of human leucocyte class I and II antigens
(HLA) in 15 pts (P). At follow-up after 6 months myocardial inflammation re-
solved in 8 pts (FU). Ventricular function was compared to 17 pts with no
inflammation (C). Systolic function was equally disturbed in all groups. Dias-
tolic dysfunction was more pronounced in pts with myocardial inflammation
and improved with resolvement of inflammation:
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(ms) (ms) (ms) (ms) (ms) (ms) (ms) (msl (ms) (ms)
Ctrl 78 1.28 130 20 135 68 68 187 115 501 175 413
±8 ±0.2 ±20 ±2 ±19 ±8 ±9 ±12 ±31 ±33 ±10 ±16
Zat 43 2.27 140 20 178 70 70 235 122 553 260 562
±9 ±03 ±29 ±2 ±24 ±8 ±9 ±13 ±32 ±35 ±14 ±15
p <0.01 <0.001 NS NS <0.01 NS NS <001 NS <001 <0.01 <0.01
ED50 023 022 0.58 - 0.57 0.76 0.60 0.78(mg!l<g)
Conclusion: At low dose, Zat has a depressant effect on sinus nodal func-
tion; at higher doses, it has additional actions on A-V nodal function and
lengthens repolarization reflecting effects on other ion channels.
Francesco Pelliccia, Giulia d'Amati, Cinzia Cianfrocca, Stefano De Castro,
Paola Bernucci, Pietro Gallo, Giuseppe Critelli. Departments of Cardiology and
Human Biopathology, University -La Sapienza~ Rome, Italy
Recent studies have shown that a paradox occurs in ischemic heart disease,
as women (W) show a higher incidence of heart failure than men (M) despite
similar LV ejection fractions. Aim of this study was to verify whether such a
"gender paradox" also exists in idiopathic dilated cardiomyopathy (lDC) and,
if so, which are the possible underlying factors. Accordingly, we analyzed
the clinical. ECG, echocardiographic, hemodynamic and LV histomorphome-
tric features of 75 IDC patients (48 M and 27 W). consecutively referred to
our Unit for invasive evaluation. W were older (55 ± 9 vs 45 ± 11 yrs, p <
0.005). more symptomatic (NYHA class III or IV in 63 vs 35%, p < 0.05), and
had more frequent signs of heart failure (70 vs 42%, p < 0.04), as compared
with M. At echocardiography, the two groups had similar LV diameter, vol-
ume and mass. Doppler examination, however, showed that W had a lower
ratio of transmitral early to late peak filling waves than M (1.0 ± 0.3 vs 1.4
± 0.4, P < O.OOll, thus indicating a worse LV diastolic filling dynamics. At
catheterization, W showed higher mean pulmonary artery pressure (25 ± 9
vs 19 ± 8 mmHg, p < 0.005). and LV end-diastolic pressure (21 ± 7 vs 16 ±
8 mmHg, p < 0.01) than M, whereas LV ejection fraction and cardiac index
were similar in both genders. Comparison of LV histomorphometric features
did not show any difference in myocellular area, nuclear area, and myofibril
volume fraction. Conversely, W had larger interstitial fibrosis (12 ± 6 vs 7
± 5%, p < 0.001). and endocardial fibrosis (15 ± 5 vs 8 ± 6%, P < 0.001).
as compared with M. It is concluded that: (1) the paradox observed in is-
chemic heart disease of more frequent symptoms and signs of heart failure
in W than in M occurs also in IDC; (2) such "gender paradox" relates to dif-
ferences between Wand M in LV diastolic function, rather than in cardiac
contractility; (3) the association of female gender with a larger accumulation
of cardiac fibrous tissue seems to constitute the morphologic substrate of
the phenomenon.
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